Bernd is the founder and managing director of CGT Solutions GmbH, a consulting company in the cell & gene therapy space. He is also an Independent Board Member of the biotech TCURX. He brings profound experience in the field of CAR-T therapy development, the commercialization of CAR-T cells as well as expertise in oncology across research, development, operations, marketing & sales, and commercialization in both pharma and biotech. Bernd spent more than 20 years at Novartis, most recently as Head Customer Operations Europe for Cell & Gene Therapies. In this role he was responsible for the patient operations and customer service deliveries along the entire cell journey including the onboarding & qualification of treatment centers. Prior to that he was responsible for the cell therapies strategy for Europe, co-led the design of the commercial model for CGT and was a member of the Global Novartis Cell & Gene Therapies Leadership Team. In prior positions at Novartis, he was Head Strategy & Operations for Northern & Central Europe, held commercial roles of increasing responsibility including Franchise Head Solid Tumors and was Global Project Team Lead for the development of a novel therapy in hematology.